Editas Medicine raises $94.4 million in year’s first IPO

By Robert Weisman — Boston Globe

February 3, 2016

MIT professor and brain researcher Feng Zhang is a cofounder of Editas Medicine. Susan Walsh/AP

Editas Medicine raises $94.4 million in year’s first IPO

About the Author

Robert Weisman — Boston Globe

robert.weisman@globe.com

Tags

Leave a Comment Cancel reply

Recommended

A deeply troubled drug company fires its CEO, who…

A deeply troubled drug company fires its CEO, who then unfires himself. Comedy, chaos ensue

Rising Drug Cost

Drug makers blamed for blocking generics have jacked up…

Drug makers blamed for blocking generics have jacked up prices and cost U.S. billions

VC Health Boot Camp

A new VC firm will invest in your startup…

A new VC firm will invest in your startup — and pay for you to get…

Recommended Stories

VC Health Boot Camp

Health

A new VC firm will invest in your startup — and pay for you to get therapy and acupuncture

By Rebecca Robbins

Adam's Take

A deeply troubled drug company fires its CEO, who then unfires himself. Comedy, chaos ensue

By Adam Feuerstein

advertisement

Rising Drug Cost

Pharma

Drug makers blamed for blocking generics have jacked up prices and cost U.S. billions

By Sydney Lupkin — Kaiser Health News

Mouse running

In the Lab

From the ‘fountain of rodent youth’ to zombie cells, scientists work to slow the aging process

By Robert Weisman — Boston Globe

Amgen

Biotech

Amgen’s new migraine drug will cost 30 percent less than Wall Street expected

By Damian Garde